Chandra A, Sharma A, Calingasan NY, White JM, Shurubor Y, X Yang W, M Beal F, Johri A.
2016.
Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease.. Hum Mol Genet. 25(11):2269-2282.
Kummer BR, Gialdini G, Sevush JL, Kamel H, Patsalides A, Navi BB.
2016.
External Validation of the Cincinnati Prehospital Stroke Severity Scale.. J Stroke Cerebrovasc Dis. 25(5):1270-1274.
Afshinnekoo E, Ahsanuddin S, Mason CE.
2016.
Globalizing and crowdsourcing biomedical research.. Br Med Bull. 120(1):27-33.
Anrather J, Iadecola C.
2016.
Inflammation and Stroke: An Overview.. Neurotherapeutics. 13(4):661-670.
Kim E, Cho S.
2016.
Microglia and Monocyte-Derived Macrophages in Stroke.. Neurotherapeutics. 13(4):702-718.
Chung SYoung, Kishinevsky S, Mazzulli JR, Graziotto J, Mrejeru A, Mosharov EV, Puspita L, Valiulahi P, Sulzer D, Milner TA et al..
2016.
Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.. Stem Cell Reports. 7(4):664-677.
Goodin DS, Reder AT, Bermel RA, Cutter GR, Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D et al..
2016.
Relapses in multiple sclerosis: Relationship to disability.. Mult Scler Relat Disord. 6:10-20.
Melman T, Victor JD.
2016.
Robust power spectral estimation for EEG data.. J Neurosci Methods. 268:14-22.
Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H.
2016.
Stroke Risk and Mortality in Patients With Ventricular Assist Devices.. Stroke. 47(11):2702-2706.
Kuceyeski A, Navi BB, Kamel H, Raj A, Relkin N, Toglia J, Iadecola C, O'Dell M.
2016.
Structural connectome disruption at baseline predicts 6-months post-stroke outcome.. Hum Brain Mapp. 37(7):2587-601.